Huntington National Bank’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-90
Closed -$1.39K 4200
2024
Q4
$1.39K Hold
90
﹤0.01% 2329
2024
Q3
$1.41K Buy
+90
New +$1.26K ﹤0.01% 2319

Other funds holding INBX

Huntington National Bank's INBX Position: Q1 2025 in Review

Huntington National Bank sold out of Inhibrx (INBX) in Q1 2025, closing a stake of 90 shares — an estimated $1.39K sold.

Huntington National Bank first reported a position in INBX in Q3 2024 and held it in 2 quarters. The position peaked at $1.41K in Q3 2024. 92 funds tracked by Wall St. Rank hold INBX as of Q1 2025.

  • Huntington National Bank reported no remaining Inhibrx position as of Q1 2025 after selling out during the quarter.
  • Huntington National Bank sold 90 Inhibrx shares in Q1 2025, an estimated $1.39K.
  • Huntington National Bank first reported a position in Inhibrx in Q3 2024 and held it in 2 quarters.
  • Huntington National Bank's Inhibrx position peaked at $1.41K in Q3 2024.
  • 92 funds tracked by Wall St. Rank held Inhibrx as of Q1 2025.

Based on Huntington National Bank's 13F filing for Q1 2025, filed 14 May 2025.